Riabni Interactions
There are 196 drugs known to interact with Riabni (rituximab), along with 7 disease interactions. Of the total drug interactions, 53 are major, 138 are moderate, and 5 are minor.
- View all 196 medications that may interact with Riabni
- View Riabni disease interactions (7)
Most frequently checked interactions
View interaction reports for Riabni (rituximab) and the medicines listed below.
- acebutolol
- acetaminophen
- Actemra (tocilizumab)
- acyclovir
- alpha-lipoic acid
- anastrozole
- azithromycin
- Belbuca (buprenorphine)
- Benadryl (diphenhydramine)
- bendamustine
- benzonatate
- budesonide
- butorphanol
- Cambia (diclofenac)
- CellCept (mycophenolate mofetil)
- ciprofloxacin
- clobetasol topical
- Coenzyme Q10 (ubiquinone)
- dexamethasone
- Dexilant (dexlansoprazole)
- dextroamphetamine
- diclofenac topical
- dihydroergotamine
- doxepin
- doxycycline
- Dulera (formoterol / mometasone)
- duloxetine
- Dyazide (hydrochlorothiazide / triamterene)
- estradiol
- famotidine
Riabni disease interactions
There are 7 disease interactions with Riabni (rituximab) which include:
- autoimmune diseases
- cardiac dysfunction
- hepatitis B
- TLS
- bone marrow suppression
- infections
- renal impairment
Report options
More about Riabni (rituximab)
- Riabni consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: CD20 monoclonal antibodies
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Tavneos
Tavneos (avacopan) is a C5a receptor antagonist used for severe active ANCA-associated vasculitis ...
Epkinly
Epkinly is used for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) ...
Imbruvica
Imbruvica (ibrutinib) is used to treat chronic lymphocytic leukemia (CLL), small lymphocytic ...
Humira
Humira is a tumor necrosis factor blocker used to treat many inflammatory conditions in adults ...
Imuran
Imuran is used for atopic dermatitis, autoimmune hepatitis, chronic active hepatitis, chronic ...
Rituxan
Rituxan infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Cytoxan
Cytoxan is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia, breast cancer ...
Ruxience
Ruxience is a biosimilar to Rituxan and is used to treat certain leukemias and lymphomas and some ...
Truxima
Truxima is used to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia, rheumatoid ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
